The standard of care for cancer patients at the UW Carbone Cancer Center (UWCCC) optimally involves a multidisciplinary team approach. The translation of laboratory discovery to clinical application is facilitated by multidisciplinary Disease Oriented Working Groups (DOWGs) and Clinical Research Groups (CRGs). DOWGs/CRGs are embedded in specific UWCCC Scientific Programs and provide a multidisciplinary translational infrastructure which fosters inter- and intra-programmatic interactions that address programmatic goals and also disease specific interests. Each DOWG/CRG has a designated leader and participants include UWCCC Scientific Program members, research staff and other UW faculty.
The DOWGs/CRGs meet regularly and interested laboratory research faculty are encouraged to actively participate. In this manner, the multidisciplinary patient care activities and their associated clinical trials research are integrated into the Scientific Programs in several meaningful and functional ways through UWCCC faculty participation and UWCCC administrative support.
The DOWGs/CRGs review and prioritize their respective clinical research activity and provide ongoing planning for new investigator-initiated studies. Proposed studies must have the support of the DOWG/CRG prior to submission to the Protocol Review and Monitoring Committee (PRMC).
Contact the DOWG/CRG leader or program manager for more information.
|DOWG or CRG
|Brain (XT)||Dr. John Kuo||Diana Trask|
|Breast Cancer (XT)||Dr. Mark Burkard
Dr. Lee G. Wilke
|Chemoprevention (CP)||Dr. Howard Bailey||Jaime Bauman|
|Endocrine (XT)||Dr. Herb Chen||Sarah Schaefer|
|Gastrointestinal Cancers (XT)||Rachel Crawford|
|Genitourinary Cancers (XT)||Dr. David Jarrard
Dr. Glenn Liu
|Mary Jane Staab|
|Gynecological Cancers (XT)||Dr. Lisa Barroilhet||Sarah Stewart|
|Head and Neck (XT)||Dr. Paul Harari
|Hematologic Malignancies (XT)||Dr. Mark Juckett||Erica Barnstable|
|Lung (Thoracic) (XT)||Dr. Anne Traynor||Elise Volkmann|
|Lymphoma (XT)||Dr. Brad Kahl||Elaine Paterson|
|Melanoma (XT)||Dr. Mark Albertini||Jennifer Collins|
|Palliative Medicine (CC)||Renae Quale|
|Pediatric Oncology (XT)||Dr. Kenneth De Santes||Jenny Kimball|
|Cancer Therapy Discovery and Development (CTD2) Clinical Research Group (XT)|
|Skin/nonmelanoma (XT)||Dr. Gary Wood||Diane Bock|
|Translational Imaging Research Working Group (IR)||Dr. Robert Jeraj||OTRS Office|
CC: Cancer Control